Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23902164)

1.

Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.

Won HS, Kim YA, Lee JS, Jeon EK, An HJ, Sun DS, Ko YH, Kim JS.

Cancer Invest. 2013 Oct;31(8):516-21. doi: 10.3109/07357907.2013.826239. Epub 2013 Jul 31.

PMID:
23902164
4.

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.

Robak T, Wierzbowska A, Błasińska-Morawiec M, Korycka A, Błoński JZ.

Mediators Inflamm. 1999;8(6):277-86.

5.

Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.

Pulsatelli L, Boiardi L, Pignotti E, Dolzani P, Silvestri T, Macchioni P, Cantini F, Salvarani C, Facchini A, Meliconi R.

Arthritis Rheum. 2008 Aug 15;59(8):1147-54. doi: 10.1002/art.23924.

7.

Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.

Karczewska-Kupczewska M, Adamska A, Nikołajuk A, Otziomek E, Górska M, Kowalska I, Strączkowski M.

Clin Endocrinol (Oxf). 2013 Dec;79(6):812-6. doi: 10.1111/cen.12118. Epub 2013 May 6.

PMID:
23199226
8.

The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.

Oelzner P, Franke S, Lehmann G, Eidner T, Hein G, Wolf G.

Rheumatol Int. 2012 Jan;32(1):199-206. doi: 10.1007/s00296-010-1606-z. Epub 2010 Sep 7.

PMID:
20821212
9.

Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.

Karczewska A, Nawrocki S, Breborowicz D, Filas V, Mackiewicz A.

Cancer. 2000 May 1;88(9):2061-71.

PMID:
10813718
10.

Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor.

Simon D, Denniston AK, Tomlins PJ, Wallace GR, Rauz S, Salmon M, Murray PI, Curnow SJ.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3988-91. doi: 10.1167/iovs.08-1953. Epub 2008 May 9.

PMID:
18469182
11.

Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.

Weiss TW, Arnesen H, Seljeflot I.

Metabolism. 2013 Jul;62(7):1008-13. doi: 10.1016/j.metabol.2013.01.019. Epub 2013 Feb 19.

PMID:
23428306
12.

Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.

Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Alevyzaki F, Zoga M, Kyritsis I, Ioannou D, Fatourou A, Nicolaou C.

Am J Nephrol. 2005 Sep-Oct;25(5):484-90. Epub 2005 Aug 26.

PMID:
16127269
13.

Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes.

Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M.

Exp Gerontol. 2001 Mar;36(3):547-57.

PMID:
11250125
14.

An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease.

Lemmers A, Gustot T, Durnez A, Evrard S, Moreno C, Quertinmont E, Vercruysse V, Demetter P, Franchimont D, Le Moine O, Geerts A, Devière J.

Clin Exp Immunol. 2009 Jun;156(3):518-27. doi: 10.1111/j.1365-2249.2009.03916.x.

15.

Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.

Migita K, Abiru S, Maeda Y, Daikoku M, Ohata K, Nakamura M, Komori A, Yano K, Yatsuhashi H, Eguchi K, Ishibashi H.

Hum Immunol. 2006 Jan-Feb;67(1-2):27-32. Epub 2006 Mar 31.

PMID:
16698422
16.

Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.

Robinson M, Gray SR, Watson MS, Kennedy G, Hill A, Belch JJ, Nimmo MA.

Scand J Med Sci Sports. 2010 Apr;20(2):282-90. doi: 10.1111/j.1600-0838.2009.00895.x. Epub 2009 Apr 13.

PMID:
19422646
17.

Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men.

Gray SR, Robinson M, Nimmo MA.

Cell Stress Chaperones. 2008 Summer;13(2):247-51. doi: 10.1007/s12192-008-0019-3. Epub 2008 Mar 5.

18.

Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.

Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW.

Metabolism. 2014 May;63(5):647-53. doi: 10.1016/j.metabol.2014.02.005. Epub 2014 Feb 14.

PMID:
24629561
19.

Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.

Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K.

J Rheumatol. 1998 Feb;25(2):308-13.

PMID:
9489824
20.

Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction.

Kaminski KA, Kozuch M, Bonda T, Wojtkowska I, Kozieradzka A, Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Winnicka MM, Musial WJ.

Atherosclerosis. 2009 Oct;206(2):581-7. doi: 10.1016/j.atherosclerosis.2009.03.033. Epub 2009 Apr 5.

PMID:
19406401
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk